Tyra Biosciences Analyst Ratings
Tyra Biosciences Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/11/2023 | 32.36% | HC Wainwright & Co. | $17 → $20 | Maintains | Buy |
08/01/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
06/30/2023 | 78.69% | Wedbush | → $27 | Initiates Coverage On | → Outperform |
05/08/2023 | 65.45% | Oppenheimer | → $25 | Reiterates | → Outperform |
05/05/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | → Buy |
03/23/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | → Buy |
03/07/2023 | 12.51% | HC Wainwright & Co. | $15 → $17 | Maintains | Buy |
03/02/2023 | -0.73% | HC Wainwright & Co. | $12 → $15 | Maintains | Buy |
02/03/2023 | 12.51% | Oppenheimer | → $17 | Initiates Coverage On | → Outperform |
06/23/2022 | -20.58% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
03/08/2022 | 78.69% | Jefferies | $31 → $27 | Upgrades | Hold → Buy |
11/08/2021 | 105.16% | Jefferies | $19 → $31 | Downgrades | Buy → Hold |
10/11/2021 | 45.6% | B of A Securities | → $22 | Initiates Coverage On | → Buy |
10/11/2021 | 25.74% | Jefferies | → $19 | Initiates Coverage On | → Buy |
10/11/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年08月11日 | 32.36% | HC Wainwright公司 | $17→$20 | 维护 | 买 |
08/01/2023 | 12.51% | HC Wainwright公司 | →$17 | 重申 | 购买→购买 |
2023/06/30 | 78.69% | 韦德布什 | →$27 | 开始承保 | →跑赢大盘 |
05/08/2023 | 65.45% | 奥本海默 | →$25 | 重申 | →跑赢大盘 |
05/05/2023 | 12.51% | HC Wainwright公司 | →$17 | 重申 | →购买 |
03/23/2023 | 12.51% | HC Wainwright公司 | →$17 | 重申 | →购买 |
03/07/2023 | 12.51% | HC Wainwright公司 | $15→$17 | 维护 | 买 |
03/02/2023 | -0.73% | HC Wainwright公司 | $12→$15 | 维护 | 买 |
02/03/2023 | 12.51% | 奥本海默 | →$17 | 开始承保 | →跑赢大盘 |
2022/06/23 | -20.58% | HC Wainwright公司 | →$12 | 开始承保 | →购买 |
03/08/2022 | 78.69% | 杰富瑞 | $31→$27 | 升级 | 持有→购买 |
11/08/2021 | 105.16% | 杰富瑞 | $19→$31 | 评级下调 | 购买→Hold |
10/11/2021 | 45.6% | B of A证券 | →$22 | 开始承保 | →购买 |
10/11/2021 | 25.74% | 杰富瑞 | →$19 | 开始承保 | →购买 |
10/11/2021 | - | 考恩公司 | 开始承保 | →跑赢大盘 |
What is the target price for Tyra Biosciences (TYRA)?
泰拉生物科学公司(Tyra)的目标价是多少?
The latest price target for Tyra Biosciences (NASDAQ: TYRA) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $20.00 expecting TYRA to rise to within 12 months (a possible 32.36% upside). 9 analyst firms have reported ratings in the last year.
泰拉生物科学公司(纳斯达克代码:TYRA)的最新目标价是由HC Wainwright&Co.于2023年8月11日报道的。这家分析公司将目标价定为20.00美元,预计Tyra将在12个月内上涨(可能上涨32.36%)。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Tyra Biosciences (TYRA)?
泰拉生物科学公司(Tyra)的最新分析师评级是多少?
The latest analyst rating for Tyra Biosciences (NASDAQ: TYRA) was provided by HC Wainwright & Co., and Tyra Biosciences maintained their buy rating.
分析师对泰拉生物科学公司(纳斯达克代码:TYRA)的最新评级由HC Wainwright&Co.提供,泰拉生物科学公司维持其买入评级。
When is the next analyst rating going to be posted or updated for Tyra Biosciences (TYRA)?
泰拉生物科学公司(Tyra)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tyra Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tyra Biosciences was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公开财务报表,与泰拉生物科学公司的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Tyra Biosciences的上一次评级是在2023年8月11日提交的,所以你应该预计下一次评级将在2024年8月11日左右提供。
Is the Analyst Rating Tyra Biosciences (TYRA) correct?
分析师对泰拉生物科学公司(Tyra)的评级正确吗?
While ratings are subjective and will change, the latest Tyra Biosciences (TYRA) rating was a maintained with a price target of $17.00 to $20.00. The current price Tyra Biosciences (TYRA) is trading at is $15.11, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的泰拉生物科学(Tyra)评级保持不变,目标价在17.00美元至20.00美元之间。泰拉生物科学公司(Tyra Biosciences)目前的股价为15.11美元,超出了分析师的预测区间。